Abstract
Purpose of Review
To review the latest information about the interactions between cancer and cerebrovascular disease.
Recent Findings
Additional data support the finding that both ischemic and hemorrhagic stroke are important complications of cancer or its treatment. Reperfusion therapy is being given successfully to patients with stroke complicating cancer.
Summary
Hemorrhagic stroke may occur with metastatic disease to the brain, coagulopathies from cancer, in particular leukemia, or as complications of chemotherapy. Ischemic stroke also may be a complication of metastatic disease with local invasion of vessels, a pro-thrombotic disorder such as non-bacterial thrombotic endocarditis (NBTE) or disseminated intravascular coagulation (DIC), or secondary to chemotherapy. Stroke also is a potential consequence of radiation therapy to the head and neck. Venous sinus thrombosis may develop with hematologic malignancies or chemotherapy. Although many patients will have a history of cancer at the time of stroke, a cerebrovascular event may be the initial manifestation of a malignancy.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Romeiro AC, Valadas A, Marques J. Acute ischemic stroke on cancer patients, a distinct etiology? A case-control study. Acta Medica Port. 2015;28:613–8.
•• Grazioli S, Paciaroni M, Agnelli G, Acciarresi M, Alberti A, D'Amore C, et al. Cancer-associated ischemic stroke: a retrospective multicentre cohort study. Thromb Res. 2018;165:33–7. Large multicenter registry of causes of stroke among patients with cancer.
Kim JM, Jung KH, Park KH, Lee ST, Chu K, Roh JK. Clinical manifestation of cancer related stroke: retrospective case-control study. J Neuro-Oncol. 2013;111:295–301.
Kassubek R, Bullinger L, Kassubek J, Dreyhaupt J, Ludolph AC, Althaus K, et al. Identifying ischemic stroke associated with cancer: a multiple model derived from a case-control analysis. J Neurol. 2017;264:781–91.
Dearborn J, Urrutia V, Zeiler S. Stroke and cancer - a complicated relationship. J Neurol Transl Neurosci. 2014;2:1039.
•• Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, et al. Cancer-associated stroke: pathophysiology, detection, and management (Review). Int J Oncol. 2019;54:779–96. Excellent updated review on stroke complicating cancer from an oncology perspective.
Cacho-Diaz B, Lorenzana-Meridoza NA, Spinola-Marono H, Reyes-Soto G, Cantu-Brito C, et al. Comorbidities, clinical features, and prognostic implications of cancer patients with cerebrovascular disease. J Stroke Cerebrovasc Dis. 2018;27:365–71.
Emre U, Gunes T, Pinar I, Kokturk F, Liman E, Yagiz O. Evaluation of ischemic stroke patients with systemic cancer. Ideggyogy Sz. 2018;71:178–83.
Kuan AS, Chen SC, Yeh CM, Hung MH, Hung YP, Chen TJ, et al. Risk of ischemic stroke in patients with gastric cancer: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94(37):e1336. https://doi.org/10.1097/MD.0000000000001336.
Kuan AS, Teng CJ, Wu HH, Su VY, Chen YT, Chien SH, et al. Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study. BMC Med. 2014;12:53. https://doi.org/10.1186/1741-7015-12-53.
Schwarzbach CJ, Schaefer A, Ebert A, Held V, Bolognese M, Kablau M, et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke. 2012;43:3029–34.
Karlinska AG, Gromadzka G, Karlinski MA, Czlonkowska A. The activity of malignancy may determine stroke pattern in cancer patients. J Stroke Cerebrovasc Dis. 2015;24:778–83.
Cutting S, Wettengel M, Conners JJ, Ouyang B, Busl K, et al. Three-month outcomes are poor in stroke patients with cancer despite acute stroke treatment. J Stroke Cerebrovasc Dis. 2017;26:809–15.
Corraini P, Ording AG, Henderson VW, Szepligeti S, Horvath-Puno S, Sorensen HT, et al. Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study. Thromb Res. 2016;147:88–93.
El-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist. 2007;12:518–23.
Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol. 2010;30:311–9.
Gundersen H, Moynihan B. An uncommon cause of stroke: non-bacterial thrombotic endocarditis. J Stroke Cerebrovasc Dis. 2016;25:163–4.
Detremerie C, Timmermans F, De Pauw M, Gheeraert P, Hemelsoet D, Toeback J, et al. Stroke due to non-bacterial thrombotic endocarditis as initial presentation of breast invasive ductal carcinoma. Acta Clin Belg. 2017;72:268–73.
Prayson RA. Intravascular lymphoma mimicking vasculitis. J Clin Neurosci. 2016;34:224–5.
Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, et al. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016;16:9. https://doi.org/10.1186/s12883-015-0509-8.
Yunce M, Muganlinskaya N, Selinger S. Intravascular large B-cell lymphoma presenting as multiple stroke: a case report. Medicine (Baltimore). 2018;97(41):e12793. https://doi.org/10.1097/MD.0000000000012793.
Arboix A. Cerebrovascular disease in the cancer patient. Rev Neurol. 2000;31:1250–2.
• Rosario M, Fonseca AC, Sotero FD, Ferro JM. Neurological complications of cardiac tumors. Neurol Syst Dis. 2019;19:15. Detailed review of stroke complicating cardiac tumors including myxomas.
Reichman J, Singer S, Navi B, Reiner A, Panageas K, Gutin PH, et al. Subdural hematoma in patients with cancer. Neurosurgery. 2012;71:74–9.
Velander AJ, DeAngelis LM, Navi BB. Intracranial hemorrhage in patients with cancer. Curr Atheroscler Rep. 2012;14:373–81.
Gon Y, Okazaki S, Terasaki Y, Sasaki T, Yoshimine T, Sakaguchi M, et al. Characteristics of cryptogenic stroke in cancer patients. Ann Clin Transl Neurol. 2016;3:280–7.
Sprugel MI, Kuramatsu JB, Gerner ST, Sembill JA, Hartwich J, Giede-Jeppe A, et al. Presence of concomitant systemic cancer is not associated with worse functional long-term outcome in patients with intracerebral hemorrhage. Cerebrovasc Dis. 2017;44:186–94.
Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119(1):1–16. https://doi.org/10.1111/j.1600-0404.2008.01059.x.
Senders JT, Goldhaber NH, Cote DJ, Muskens IS, Dawood HY, DeVos FYFL, et al. Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis. J Neuro-Oncol. 2018;136:135–45.
Bhatia R, Rowley HD, Mosher JC, Alsheik NH, Aagaard-Kienitz B, Diamond CD, et al. Extensive sinovenous thrombosis and hemorrhage infarction during therapy for T-cell acute lymphoblastic leukemia. Pediatr Emerg Care. 2013;29:93–7.
• Merkler AE, Navi BB, Singer S, Cheng NT, Stone JB, Kamel H, et al. Diagnostic yield of echocardiography in cancer patients with ischemic stroke. J Neuro-Oncol. 2015;123:115–21. Large series reviewing the yield of TTE and TEE when screening patients with stroke and cancer.
Wen XY, Chen YM, Yu LL, Wang SR, Zheng HB, Chen ZB, et al. Neurological manifestations of atrial myxoma: a retrospective analysis. Oncol Lett. 2018;16:4635–9.
Nomoto N, Tani T, Kim K, Kitai T, Ota M, Kaji S, et al. Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15 year single center study. J Card Surg. 2017;12:103.
Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62:2025–30.
Bonnerot M, Humbertiean L, Mione G, Lacour JC, Derelle AL, Sanchez JC, et al. Cerebral ischemic events in patients with pancreatic cancer: a retrospective cohort study of 17 patients and a literature review. Medicine (Baltimore). 2016;95(26):e4009. https://doi.org/10.1097/MD.0000000000004009.
Nam KW, Kim CK, Kim TJ, An SJ, Oh K, Ko SB, et al. Intravenous thrombolysis in acute ischemic stroke with active cancer. Biomed Res Int. 2017;2017:4635829. https://doi.org/10.1155/2017/4635829.
Murthy SB, Moradiya Y, Shah S, Shastri A, Bershad EM, Suarez JI. In-hospital outcomes of thrombolysis for acute ischemic stroke in patients with primary brain tumors. J Clin Neurosci. 2015;22:474–8.
Geraldes T, Pereira L, Guarda C, Grunho M, Ribeiro AC, Coimbra J, et al. Safety and outcome of rtPA in acute ischemic stroke in patients with active cancer: case-control study. Rev Neurol. 2017;61:13–8.
Jung S, Jung C, Hyoung KJ, Se Choi B, Jung Bae Y, Sunhoo L, et al. Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke. Interv Neuroradiol. 2018;24:520–8.
Kawano H, Honda Y, Amano T, Okano H, Suzuki R, Torii M, et al. Subcutaneous heparin therapy for patients with cancer-associated stroke. J Stroke Cerebrovasc Dis. 2019;28:399–404.
• Eschle D. Stroke and cancer: are cryptogenic strokes a paraneoplastic syndrome? Praxis (Bern 1994). 2015;104:795–802. A commentary about the potential cause and effect relationship between cancer and stroke with a particular emphasis on immune mechanisms that promote thrombosis.
Shin YW, Lee ST, Jung KH, Kim DY, Park CK, Kim TM, et al. Predictors of survival for patients with cancer after cryptogenic stroke. J Neuro-Oncol. 2016;128:277–84.
Lee YJ, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH, et al. Bleeding risk and major adverse events in patients with cancer on oral anticoagulation. Ther Int J Cardiol. 2016;203:372–8.
Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, et al. Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial. Am J Med. 2017;130:1440–8.
Naito H, Nezu T, Hosomi N, Aoki S, Ueno H, Ochi K, et al. Antithrombotic therapy strategy for cancer-associated ischemic stroke: a case series of 26 patients. J Stroke Cerebrovasc Dis. 2018;27:e206–e11.
Baikoussis NG, Papakonstantinou NA, Dedeilias P, Argiriou M, Apostolakis E, Koletsis E, et al. Cardiac tumors: a retrospective multicenter institutional study. J BUON. 2015;20:1115–23.
Carino D, Nicolini F, Molardi A, Indira Dadamo C, Gherli T. Unusual locations for cardiac papillary fibroelastomas. J Heart Valve Dis. 2017;26:226–30.
Pun SC, Plodkowski A, Matasar MJ, Lakhman Y, Halpenny DF, Gupta D, et al. Pattern and prognostic implications of cardiac metastases among patients with advanced systemic cancer assessed with cardiac magnetic resonance imaging. J Am Heart Assoc. 2016;5(5):e003368. https://doi.org/10.1161/JAHA.116.003368.
Noje C, Cohen K, Jordan LC. Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013;49:237–42.
Bright CJ, Hawkins MM, Guha J, Henson KE, Winter DL, Kelly JS, et al. Risk of cerebrovascular events in 178 962 five-year survivors of cancer diagnosed at 15 to 39 years of age. Circulation. 2017;135:1194–210.
Chow EJ, Chen Y, Hudson MM, Fiejen E, Kremer LC, Border WL, et al. Prediction of ischemic heart disease and stroke in survivors of childhood cancer. J Clin Oncol. 2018;36:44–52.
Fullerton HJ, Stratton K, Mueller S, Leisenring WW, Armstrong GT, Weathers RE. Recurrent stroke in childhood cancer survivors. Neurology. 2015;85:1056–64.
El-Fayech C, Haddy N, Allodji RS, Veres C, Diop F, Kahlouche E, et al. Cerebrovascular diseases in childhood cancer survivors: role of the radiation dose to Willis circle arteries. Int J Radiat Oncol Biol Phys. 2017;97(2):278–86. https://doi.org/10.1016/j.ijrobp.2016.10.015.
Addison D, Seidelmann SB, Janjua SA, Emami H, Staziaki PV, Hallett TR, et al. Human papillomavirus status and the risk of cerebrovascular events following radiation therapy for head and neck cancer. J Am Heart Assoc. 2017;6(9):e006453. https://doi.org/10.1161/JAHA.117.006453.
Larsen AM, Cote DJ, Karhade AV, Smith TR. Predictors of stroke and coma after neurosurgery: an ACS-NSQIP analysis. World Neurosurgery. 2016;93:299–305.
Macneil SD, Liu K, Garg AX, Tam S, Palma D, Thind A, et al. A population-based study of 30-day incidence of ischemic stroke following surgical neck dissection. Medicine (Baltimore). 2015;94(33):e1106. https://doi.org/10.1097/MD.0000000000001106.
Mourad M, Saman M, Stroman D, Lee T, Ducic Y. Carotid artery sacrifice and reconstruction in the setting of advanced head and neck cancer otolaryngol. Head Neck Surg. 2015;153:225–30.
Soussain C, Ricard D, Fike J, Mazeron JJ, Psimaras D, Delattre JV, et al. CNS complications of radiotherapy and chemotherapy. Lancet. 2009;374:1639–51.
Hall MD, Bradley JA, Rotondo RL, Hanel R, Shah C, Morris CG, et al. Risk of radiation vasculopathy and stroke in pediatric patients treated with proton therapy for brain and Skull Base tumors. Int J Radiat Oncol Biol Phys. 2018;101:854–9.
Aizer AA, Du R, Wen PY, Arvold ND. Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors. J Neuro-Oncol. 2015;124:291–7.
•• Van Dijk IW, Van Der Pal HJ, Van Os RM, Roos YB, Jieswerda E, Van Dalen EC, et al. Risk of symptomatic stroke after radiation therapy for childhood cancer: a long-term follow-up cohort analysis. Int J Radiat Oncol Biol Phys. 2016;96:597–605. Population based project describing the long-term risks of stroke among people who were treated by radiation therapy in childhood.
Passos J, Nzwalo H, Marques J, Azevedo A, Netto E, Nunes S, et al. Late cerebrovascular complications after radiotherapy for childhood primary central nervous system tumors. Pediatr Neurol. 2015;53:211–5.
Van Westrhenen A, Muskens IS, Verhoeff JJC, Smith TRS, Broekman MLD. Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review. J Neuro-Oncol. 2017;135:1–11.
Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the childhood cancer survivor study. J Clin Oncol. 2006;24:5277–82.
Partap S. Stroke and cerebrovascular complications in childhood cancer survivors. Semin Pediatr Neurol. 2012;19:18–24.
Wu YH, Chang FC, Liang ML, Chen HH, Wong TT, Yen SH. Incidence and long-term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan. Cancer Med. 2016;5:2155–60.
Black D, Bartleson J, Bell M, Lachance D. SMART: stroke-like migraine attacks after radiation therapy. Cephalagia. 2006;26:1137–42.
Partap S, Walker M, Longstreth WT Jr, Spence AM. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology. 2006;66:1105–7.
Maraldo MV, Brodin P, Aznar MC, Vogelius IR, Rosenschold MP, Petersen PM, et al. Doses to caraotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment? Int J Radiat Oncol Biol Phys. 2013;87:297–303.
Cheng SW, Ting AC, Ho P, Wu LL. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg. 2004;39:409–15.
Gujral DM, Chahal N, Senior R, Harrington KJ, Nutting CM. Radiation-induced carotid artery atherosclerosis. Radiother Oncol. 2014;110:31–8.
Arthurs E, Hanna T, Zaza K, Peng Y, Hall SF. Stroke after radiation therapy for head and neck cancer: what is the risk? Int J Radiat Oncol Biol Phys. 2016;96:589–96.
Bond KM, Brinjikji W, Murad MH, Cloft HJ, Lanzino G. Endovascular treatment of carotid blowout syndrome. J Vasc Surg. 2017;65:883–8.
Powitzky R, Vasan N, Krempl G, Medina J. Carotid blowout in patients with head and neck cancer. Ann Otol Rhinol Laryngol. 2010;119:476–84.
Suarez C, Fernandez-Alvarez V, Hamoir M, Mendenhall WM, Strojan P, Quer M, et al. Carotid blowout syndrome: modern trends in management. Cancer Manag Res. 2018;10:5617–28. https://doi.org/10.2147/CMAR.S180164 eCollection 2018.
Li SH, Chen WH, Tang Y, Rau KM, Chen YY, Huang TL, et al. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg. 2006;108:150–6.
Saynak M, Cosar-Alas R, Yurut-Caloglu V, Caloglu M, Kocak Z, Uzal C. Chemotherapy and cerebrovascular disease. J BUON. 2008;13:31–6.
Cerrud-Rodriguez R, Quinteros MG, Azam M. Internal carotid artery occlusion and stroke as a complication of cisplatin-based chemotherapy for metastatic testicular germ cell tumour. BMJ Case Rep. 2017;2017:bcr-2017–220084. https://doi.org/10.1136/bcr-2017-220084.
Fitzpatrick T, Carrier M, Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb Res. 2017;155:101–5.
Ferroni P, Della-Morte D, Palmirotta R, McClendon M, Testa G, Abete P, et al. Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention. Rejuvenation Res. 2011;14:293–308.
Weijl NI, Rutten MF, Zwinderman AH, Keizer HJ, Nooy MA, Rosendaal FR. Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol. 2000;18:2169–78.
Zuurbier SM, Hiltunen S, Lindgren E, Silvis SM, Jood K, Devasagayam S, et al. Cerebral venous thrombosis in older patients. Stroke. 2018;49:197–200.
Letarte N, Bressler LR, Villano JL. Bevacizumab and central nervous system (CNS) hemorrhage. Cancer Chemother Pharmacol. 2013;71:1561–5.
Zuo PY, Chen XL, Liu YW, Xiao CL, Liu CY. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. PLoS One. 2014;9(7):e102484. https://doi.org/10.1371/journal.pone.0102484 eCollection 2014.
Auer TA, Renovanz M, Marini F, Brockmann MA, Tanyildizi Y. Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab. J Neuro-Oncol. 2017;133:571–9.
Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostroynaya I, Furberg HF, et al. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer. 2016;22:712–21.
Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior reversible encephalopathy syndrome in patients with cancer. Oncologist. 2015;20:806–11.
Qureshi AI, Malik AA, Saeed O, Adil MM, Rodriguez GJ, Suri MF. Incident cancer in a cohort of 3,247 cancer diagnosis free ischemic stroke patients. Cerebrovasc Dis. 2015;39:262–8.
Quintas S, Rogado J, Gullon P, Pacheco-Barcia V, Dotor-Garcia-Soto J, Reig-Rosello G, et al. Predictors of unknown cancer in patients with ischemic stroke. J Neuro-Oncol. 2018;137:551–7. https://doi.org/10.1007/s11060-017-2741-0.
Selvik HA, Thomassen L, Bjerkreim AT, Naess H. Cancer-associated stroke: the Bergen NORSTROKE study. Cerebrovasc Dis Extra. 2015;5:107–13.
• Jacob L, Kostev K. Cancer risk in Stroke survivors followed for up to 10 years in general practices in Germany. J Cancer Res Clin Oncol. 2019;145:1013–20. Important epidemiology study on the frequency of cancer among patients who have had stroke.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Harold P. Adams Jr. declares no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Neurology of Systemic Diseases
Rights and permissions
About this article
Cite this article
Adams, H.P. Cancer and Cerebrovascular Disease. Curr Neurol Neurosci Rep 19, 73 (2019). https://doi.org/10.1007/s11910-019-0985-0
Published:
DOI: https://doi.org/10.1007/s11910-019-0985-0